Advisor Group Inc. boosted its position in Masimo Corporation (NASDAQ:MASI) by 38.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,361 shares of the medical equipment provider’s stock after purchasing an additional 655 shares during the period. Advisor Group Inc.’s holdings in Masimo Corporation were worth $216,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently made changes to their positions in MASI. Fortaleza Asset Management Inc. acquired a new stake in Masimo Corporation in the second quarter valued at about $106,000. Dubuque Bank & Trust Co. lifted its position in shares of Masimo Corporation by 3.4% during the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after acquiring an additional 61 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Masimo Corporation by 13.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock valued at $184,000 after acquiring an additional 236 shares during the period. Campbell & CO Investment Adviser LLC acquired a new stake in shares of Masimo Corporation during the 2nd quarter valued at approximately $203,000. Finally, Neuberger Berman Group LLC acquired a new stake in shares of Masimo Corporation during the 1st quarter valued at approximately $206,000. Hedge funds and other institutional investors own 83.21% of the company’s stock.
Shares of Masimo Corporation (NASDAQ:MASI) opened at 85.50 on Wednesday. The firm has a market capitalization of $4.44 billion, a P/E ratio of 14.01 and a beta of 0.82. The stock’s 50 day moving average is $85.41 and its 200-day moving average is $89.87. Masimo Corporation has a 52-week low of $53.78 and a 52-week high of $104.71.
Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. The business had revenue of $192.90 million during the quarter, compared to analysts’ expectations of $189.03 million. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The business’s revenue was up 11.8% on a year-over-year basis. During the same period last year, the firm posted $0.57 earnings per share. On average, equities analysts forecast that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.
In other news, Director Sanford Fitch sold 11,000 shares of the stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the completion of the transaction, the director now directly owns 72,249 shares in the company, valued at $6,303,725.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jon Coleman sold 25,000 shares of the stock in a transaction that occurred on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares of the company’s stock, valued at $3,139,597.50. The disclosure for this sale can be found here. Company insiders own 16.60% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Masimo Corporation (MASI) Position Raised by Advisor Group Inc.” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://sportsperspectives.com/2017/10/18/masimo-corporation-masi-position-raised-by-advisor-group-inc.html.
A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Monday, August 14th. BidaskClub downgraded shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Stifel Nicolaus reiterated a “buy” rating and set a $108.00 price target (up from $105.00) on shares of Masimo Corporation in a research report on Thursday, August 3rd. Finally, Roth Capital lifted their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company. Masimo Corporation presently has an average rating of “Hold” and an average price target of $97.00.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.